Health Expenses and Outcomes of the DASH Diet in Egyptian Patients With Hypertension

NCT06499194 | Completed

• 1 other identifier: DASH diet and hypertension
• Study Type: interventional
• Target: 364
• Locations: 1 country
• Sites: 1

Brief Summary

DASH diet can reduce hypertension and decrease health expenses

Conditions

Hypertension,Essential

Keywords

DASH diet; hypertension; health expense

Outcome Measures

Primary Outcomes (1)

• blood pressure

  patient on DASH diet showing decrease on blood pressure

  9 month

Study Arms (2)

intervention group

ACTIVE COMPARATOR

Participants will taken a medical history review, anthropometric assessments, and waist circumference measurements. Tests included hemoglobin levels, kidney and liver function tests, fasting blood glucose, and lipid profiles. Baseline antihypertensive medications will be recorded in an Excel sheet and taken DASH diet .

Other: DASH diet

control group

PLACEBO COMPARATOR

Participants will taken a medical history review, anthropometric assessments, and waist circumference measurements. Tests included hemoglobin levels, kidney and liver function tests, fasting blood glucose, and lipid profiles. Baseline antihypertensive medications will be recorded in an Excel sheet and without taken DASH diet .

Other: DASH diet

Interventions

DASH diet OTHER

The Dietary Approaches to Stop Hypertension (DASH) diets rich in fruits and vegetables and reduced in saturated fat can lower the risk for high blood pressure and assist with blood pressure control in hypertensive persons

control group; intervention group

Eligibility Criteria

• Age: 30 Years - 60 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• patients diagnosed with primary hypertension (all stages) in the family medicine units of Esna Health Administration, located in Luxor Governorate.
• Individuals between the ages of 30 and 60, of both male and female genders.

You may not qualify if:

• Patients with cancer and either hepatic failure or renal impairment.
• Patients diagnosed with diabetes, metabolic illness, or terminal organ failure.
• A patient with severe or malignant hypertension.
• Individuals who decline to partake in our research.

Sponsors & Collaborators

• Beni-Suef University: lead

Study Sites (1)

Faculty of Medicine

Banī Suwayf, 621125, Egypt

Location

Related Publications (5)

• Abolfotouh MA, Soliman LA, Abolfotouh SM, Raafat M. Knowledge and Practice of PHC Physicians toward the Detection and Management of Hypertension and Other CVD Risk Factors in Egypt. Int J Hypertens. 2011;2011:983869. doi: 10.4061/2011/983869. Epub 2011 Aug 11.

  PMID: 21860783 BACKGROUND

• Akhlaghi M. Dietary Approaches to Stop Hypertension (DASH): potential mechanisms of action against risk factors of the metabolic syndrome. Nutr Res Rev. 2020 Jun;33(1):1-18. doi: 10.1017/S0954422419000155. Epub 2019 Jul 30.

  PMID: 31358075 BACKGROUND

• Al-Smair A, Saadeh O, Saadeh A, Al-Ali A. Renovascular Compression by the Diaphragmatic Crus: A Case Report. Cureus. 2022 Apr 10;14(4):e24004. doi: 10.7759/cureus.24004. eCollection 2022 Apr.

  PMID: 35547452 BACKGROUND

• Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997 Apr 17;336(16):1117-24. doi: 10.1056/NEJM199704173361601.

  PMID: 9099655 BACKGROUND

• Ancker OV, Wehland M, Bauer J, Infanger M, Grimm D. The Adverse Effect of Hypertension in the Treatment of Thyroid Cancer with Multi-Kinase Inhibitors. Int J Mol Sci. 2017 Mar 14;18(3):625. doi: 10.3390/ijms18030625.

  PMID: 28335429 BACKGROUND

MeSH Terms

Conditions

Essential Hypertension; Hypertension

Interventions

Dietary Approaches To Stop Hypertension

Condition Hierarchy (Ancestors)

Vascular Diseases; Cardiovascular Diseases

Intervention Hierarchy (Ancestors)

Diet Therapy; Nutrition Therapy; Therapeutics; Diet; Nutritional Physiological Phenomena; Diet, Food, and Nutrition; Physiological Phenomena

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Mohamed Hassan Street from Salah Salem Street, Beni-Suef

Model Details: an Open-label parallel design prospective controlled clinical trial

Study Record Dates

• First Submitted: July 6, 2024
• First Posted: July 12, 2024
• Study Start: January 1, 2023
• Primary Completion: October 29, 2023
• Study Completion: June 29, 2024
• Last Updated: July 12, 2024

Record last verified: 2024-07

Data Sharing

• IPD Sharing: Will not share

Locations

EG (1)